Lisa Kohler, MD - AkronCantonMDNews

Bariatric & Metabolic Institute. He is also
the past president of the American Society
of Metabolic and Bariatric Surgery.
Dr. Bipan Chand is the director
of Surgical Endoscopy, Advanced
Laparoscopic and Bariatric Surgery, and
staff surgeon at the Cleveland Clinic
Bariatric & Metabolic Institute.
Dr. Stacy Brethauer is the assistant
Laparoscopic Fellowship director and associate
staff surgeon at the Cleveland Clinic
Bariatric & Metabolic Institute.
Dr. Tomasz Rogula is an associate staff
surgeon at the Cleveland Clinic Bariatric
& Metabolic Institute.
PHOTO COURTESY OF CLEVELAND CLINIC
mortality rate of approximately 0.3 % and a major complication
rate of 5%, the strong potential for diabetes remission and
even improvement in longterm survival does suggest that the
perioperative risks are justified.
Perhaps in the very near future, bariatric operations will be integrated
into standard clinical pathways for treating type 2 diabetes
in obese and severely obese patients.
For more information, call 216-444-4794. ■
About the authors of this article:
Dr. Philip Schauer is professor of Surgery, Cleveland Clinic
Lerner College of Medicine, and director of the Cleveland Clinic
References
1. Pories WJ, Swanson MS, MacDonald KG,
et al. Who would have thought it? An operation
proves to be the most effective therapy for adult-onset
diabetes mellitus. Ann Surg. 1995; 222:339-352
2. Schauer PR, Burguera B, Ikramuddin S,
Cottam D, Gourash W. Hamad G, Eid GM,
Mattar S, Ramanathan R, Barinas-Mitchel
E, Rao RH, Kuller L, Kelley D. Effect of
laparoscopic Roux-en-Y gastric bypass on type 2
diabetes mellitus. Ann Surg 2003 238:467-484;
discussion 84-85
3. Sugarman HJ, Wofe LG, Sica DA, Clore JN.
Diabetes and hypertension in severe obesity and effects
of gastric bypass-induced weight loss. Ann Srg
237: 751-756; discussion 2003 757-758
4. Wittgrove AC, Clark GW. Laparoscopic
gastric bypass, Roux-en-Y-500 patients: technique
and results, with 3-60 month follow-up. Obes Surg
2000 10:233-239
5. Schauer PR, Ikramuddin S, Gourash W, et
al. Outcomes after laparoscopic Roux-en-Y gastric
bypass for morbid obesity. Ann Surg. 2000; 232:
515-529
6. Long SD, O’Brien K, MacDonald Jr. KG,
Leggett-Frazier N, Swanson MS, Pories WJ,
Caro JF. Weight loss in severely obese subjects prevents the progression of impaired
glucose tolerance to type 2 diabetes. A longitudinal interventional study.
Diabetes Care 1994 17:372-375
7. Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases longterm
mortality, morbidity, and health care use in morbidly obese patients. Ann
Surg 2004; 240_416-423; discussion 423-424.
8. Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: a
population-based analysis. J Am coll surg 2004; 199: 543-551.
9. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic
review and meta-analysis. JAMA 2004; 292: 1724-1737.
10. Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on
mortality in Swedish obese subjects. N Engl J Med. 2007 Aug 23; 357(8): 741-52.
11. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric
bypass surgery. N Engl J Med. 2007 Aug 23; 357(8): 753-61.
1 4 | GREATER AKRON/CANTON M.D. NEWS JANUARY-FEBRUARY 2008
1 4 | GREATER AKRON/CANTON M.D. NEWS JANUARY-FEBRUARY 2008